Genex India Bioscience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.00 M
as on 16-11-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.21 Cr
as on 16-11-2024
- Satisfied Charges ₹ 3.40 Cr
as on 16-11-2024
- Revenue 7.82%
(FY 2023)
- Profit -63.40%
(FY 2023)
- Ebitda -57.27%
(FY 2023)
- Net Worth 12.99%
(FY 2023)
- Total Assets 1.75%
(FY 2023)
About Genex India Bioscience
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹8.21 Cr. The company has closed loans amounting to ₹3.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mary Rani and Felix Paul serve as directors at the Company.
- CIN/LLPIN
U51103TN2009PTC072506
- Company No.
072506
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Genex India Bioscience Private Limited offer?
Genex India Bioscience Private Limited offers a wide range of products and services, including Clinical Reagents, Diagnostic Reagents, Laboratory Chemicals, Cell Culture Media, Medical Surgery & Treatment Centres, Medical Facilities, Biometric Access Control System, Realtime Biometric Machine, Network Multiplexer.
Who are the key members and board of directors at Genex India Bioscience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Felix Paul  | Managing Director | 07-Aug-2009 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mary Rani | Director | 07-Aug-2009 | Current |
Financial Performance of Genex India Bioscience.
Genex India Bioscience Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.82% increase. The company also saw a substantial fall in profitability, with a 63.4% decrease in profit. The company's net worth Soared by an impressive increase of 12.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genex India Bioscience?
In 2023, Genex India Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Diagenode Diagnostics India Private LimitedActive 9 years 2 monthsMary Rani and Felix Paul are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 28 Apr 2023 | ₹3.21 Cr | Open |
Axis Bank Limited Creation Date: 02 Jan 2010 | ₹5.00 Cr | Open |
Others Creation Date: 31 Oct 2021 | ₹3.40 Cr | Satisfied |
How Many Employees Work at Genex India Bioscience?
Genex India Bioscience has a workforce of 30 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genex India Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genex India Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
